Earnings per share (EPS) increased to 2.42 cents in FY2023 from 2.30 cents a year ago on a fully diluted basis.
Medical oncology and stem cell services provider TalkMed Group (SGX:5G3
) has reported earnings of $32.7 million for the FY2023 ended Dec 31, 2023, up 9.7% from its earnings of $29.8 million in FY2022.
For 2HFY2023, earnings increased 4% y-o-y to $18.5 million.
![[19/05/26] new top stories](/_next/image?url=https%3A%2F%2Fedgemarkets-transferred.s3-ap-southeast-1.amazonaws.com%2FPEO_KUNHEE_PARK_01_AC_2.jpg%3FTd3bG7fJqxPW3hMZRxhyfGgI25yRRD5v&w=640&q=75)
